10:00 AM ET
8-K
Investor Presentation
X4 Pharmaceuticals Investor Presentation
X4 Pharmaceuticals is hosting a Virtual Investor Day on October 29, 2026, to provide updates on its strategic business plans and clinical pipeline. The presentation focuses on the commercialization of mavorixafor for primary chronic neutropenia and the progress of the ongoing 4WARD Phase 3 clinical study.